Iver Kristiansen Nordentoft

Associate Professor

Aarhus Universitetshospital

Denmark

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (16)

Sia Viborg Lindskrog

Aarhus University

DENMARK

View details

Tenna Henriksen

Aarhus University

DENMARK

View details

Jakob S Pedersen

Aarhus University

DENMARK

View details

Karin Birkenkamp-Demtröder

Aarhus University

DENMARK

View details

Jørgen Bjerggaard Jensen

Aarhus University

DENMARK

View details

Lars Dyrskjøt

Aarhus University Hospital

DENMARK

View details

Amanda Frydendahl

Aarhus University

DENMARK

View details

Asbjørn Kjær

Aarhus University

DENMARK

View details

Francesc Castro-Giner

Head of Computational Biology

ETH Zürich

SWITZERLAND

View details

Claus Lindbjerg Andersen

Aarhus University

DENMARK

View details

Mads Agerbaek

Aarhus University

DENMARK

View details

Roland Schwarz

Professor

GERMANY

View details

Margaret Knowles

University of Leeds

UNITED KINGDOM

View details

John Le Quesne

Professor of Molecular Pathology

University of Glasgow

UNITED KINGDOM

View details

Søren Vang

DVIP-external, Head of Clinical Bioinformatics

Aarhus University

DENMARK

View details

Mads Heilskov Rasmussen

VIP, Associate Professor

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iver Kristiansen Nordentoft

Research Interests

Explore related searches

Contact this professor

Articles (19)

Beyond basics: Key mutation selection features for successful tumor‐informed ctDNA detection

Abstract 3668: Plasma cell-free DNA profiling for deciphering cellular origins and immune competence in cancer patients

Abstract 5216: Peripheral T cell receptor repertoire diversity is associated with outcome in bladder cancer

Multiomics profiling of urothelial carcinoma <i>in situ</i> reveals CIS-specific gene signature and immune characteristics.

Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer

Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer.

NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.

Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases

Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.

Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.

<i>SPTAN1</i>, <i>APC</i>, <i>and FGFR3</i> Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer.

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.

Pervasive chromosomal instability and karyotype order in tumour evolution.

Epigenetic and transcriptomic consequences of excess X-chromosome material in 47,XXX syndrome-A comparison with Turner syndrome and 46,XX females.

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.

Collaborators (16)

Sia Viborg Lindskrog

Tenna Henriksen

Jakob S Pedersen

Karin Birkenkamp-Demtröder

Jørgen Bjerggaard Jensen

Lars Dyrskjøt

Amanda Frydendahl

Asbjørn Kjær

Francesc Castro-Giner

Claus Lindbjerg Andersen

Mads Agerbaek

Roland Schwarz

Margaret Knowles

John Le Quesne

Søren Vang

Mads Heilskov Rasmussen

Make your next move.